Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration
Status:
Terminated
Trial end date:
2011-02-01
Target enrollment:
Participant gender:
Summary
Aspirin has shown to be beneficial to some patients with certain diseases such as coronary
artery disease or stroke. We are investigating how aspirin works on regulating platelets and
thromboxane over time at different doses. We hope to find the best dose of aspirin and/or
other medications to help people who are at risk for heart attack or stroke.
Phase:
Phase 4
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center